HRTX

HRTX

USD

Heron Therapeutics Inc. Common Stock

$1.105-0.065 (-5.556%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.170

Hoch

$1.190

Tief

$1.070

Volumen

1.54M

Unternehmensfundamentaldaten

Marktkapitalisierung

202.6M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.92M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.04Aktuell $1.105Hoch $2.68

Ähnliche Nachrichten

GlobeNewswire

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net

Mehr anzeigen
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
GlobeNewswire

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board

Mehr anzeigen
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
GlobeNewswire

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call

Mehr anzeigen
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.